Daniel Contreras on 09th Oct

Roche unveils pioneering results of new Multiple Sclerosis drug

Roche Pharmaceuticals Division (SWX:RO) has announced the drug Ocrelizumab is the first investigational medicine to show...

Read More
Daniel Contreras on 08th Oct

Roche’s Multiple Sclerosis drug shows promising results

A new drug developed by Roche Pharmaceuticals can decrease Multiple Sclerosis (MS) relapses by almost 50 percent. The Swiss...

Read More